Things For Investors To Watch In MultiPlan Corp (NYSE: MPLN)

money audit

MultiPlan Corp (NYSE:MPLN) does about 3.41M shares in volume on a normal day but saw 2143024 shares change hands in the recent trading day. The company now has a market cap of 164.66M USD. Its current market price is $0.25, marking a decrease of -8.67% compared to the previous close of $0.28. The 52 week high reached by this stock is $2.15 whilst the lowest price level in 52 weeks is $0.26.

MultiPlan Corp (MPLN) has a 20-day trading average at $0.3944 and the current price is -88.17% off the 52-week high compared with -3.04% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3957 and its 200-day simple moving average is $0.9062. If we look at the stock’s price movements over the week, volatility stands at 31.64%, which decreases to 18.40% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 37.19 to suggest the stock is neutral.

The consensus objective for the share price is $0.81, suggesting that the stock has a potential upside of 69.14% over the period.

0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Hold and Wall Street’s advice is for investors to Moderate Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on June 26, 2024 when Piper Sandler initiated the stock to “Neutral” and issued a price target of $2. Citigroup downgraded the stock to “Neutral” from Buy on December 13, 2022 at a price target of $3-$2. Goldman initiated its price target at $6.50.

MultiPlan Corp (MPLN) stock is down -25.55% over the week and -30.84% over the past month. Its price is -82.29% year-to-date and -87.74% over the past year.

To reach the target analysts have set, the stock logically needs to grow 69.14 percent from here.

The company has a return on investment of -22.85% and return on equity of -98.82%. The beta has a value of 0.85. Price to book ratio is 0.27 and price to sales ratio is 0.17.